Advertisement
After adjustment for the nonrandom exit of clinicians

MSSP ACOs May Not Improve Spending, Quality of Care

0
After adjustment for clinicians' nonrandom exit, no link seen with improvements in spending, quality
Combining ivermectin cream and doxycycline modified-release capsules can improve response rates for patients with severe rosacea

Combination Therapy for Rosacea Shows Improved Response Rates

0
Combination of ivermectin cream, doxycycline modified-release capsules has faster onset of action
The U.S. Food and Drug Administration on Tuesday took two kratom marketers to task over false claims that their products can treat or cure opioid addiction.

FDA Warns Two Kratom Marketers About False Claims

0
Warning letters sent to companies illegally selling unapproved, misbranded kratom-containing drug products
Even with dietary supplements

Nutrient Intake Inadequate in Many Pregnant Women in U.S.

0
Almost all at risk for excessive sodium consumption
Exposure to anticholinergic drugs is associated with an increased dementia risk

Exposure to Anticholinergics May Increase Dementia Risk

0
Risk up for exposure to anticholinergics including antidepressants, antiparkinson drugs, antipsychotics
There is little association between iron intake and chances of conception overall

Iron Intake May Not Improve Pregnancy Chances

0
Modest benefits seen from nonheme iron for women at risk for iron deficiency
For individuals with sickle cell disease

Voxelotor Improves Hemoglobin Levels in Sickle Cell Disease

0
Fewer individuals in voxelotor group versus placebo group have worsened anemia at week 24
Multiple exposures to general anesthesia may be associated with neurocognitive impairment and brain imaging abnormalities in long-term survivors of childhood acute lymphoblastic leukemia

Anesthesia Tied to Neurocognitive Impairment in Childhood ALL Survivors

0
Survivors experience impairment with exposure to propofol, fluranes, longer anesthesia duration
Vyleesi (bremelanotide) has been approved to treat acquired

Vyleesi Approved for Hypoactive Sexual Desire Disorder in Women

0
FDA approved Vyleesi for premenopausal women; drug administered by subcutaneous injection
Treatment with a combination of alpelisib and fulvestrant prolongs progression-free survival among patients with PIK3CA-mutated

Drug Combo Slows Progression in Advanced Breast Cancer

0
Results seen for alpelisib plus fulvestrant in PIK3CA-mutated, HR+, HER2− advanced breast cancer